# Mg Sulfate Versus Dexmedetomidine on Cerebral Oxygen Saturation

> **NCT06848595** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Tanta University** · enrollment: 90 (estimated)

## Conditions studied

- Cerebral Desaturation Events
- Spine Surgeries

## Interventions

- **PROCEDURE:** spine surgery
- **DRUG:** Magnesium sulfate
- **DRUG:** Dexmedetomidine
- **DRUG:** Normal Saline (0.9% NaCl)

## Key facts

- **NCT ID:** NCT06848595
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-23
- **Primary completion:** 2027-01-20
- **Final completion:** 2027-01-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06848595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06848595, "Mg Sulfate Versus Dexmedetomidine on Cerebral Oxygen Saturation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06848595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*